{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:07:36Z","timestamp":1790374056481,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) represents a major healthcare burden with no effective treatment. The glutamate modulator, riluzole, was shown to reverse many AD-related gene expression changes and improve cognition in aged rats. However, riluzole\u2019s effect on amyloid beta (A\u03b2) pathology, a major histopathological hallmark of AD, remains unclear. 5XFAD transgenic mice, which harbor amyloid \u03b2 precursor protein (APP) and presenilin mutations and exhibit early A\u03b2 accumulation, were treated with riluzole from 1 to 6 months of age. Riluzole significantly enhanced cognition and reduced A\u03b242, A\u03b240, A\u03b2 oligomers levels, and A\u03b2 plaque load in 5XFAD mice. RNA-Sequencing showed that riluzole reversed many gene expression changes observed in the hippocampus of 5XFAD mice, predominantly in expression of canonical gene markers for microglia, specifically disease-associated microglia (DAM), as well as neurons and astrocytes. Central to the cognitive improvements observed, riluzole reversed alterations in NMDA receptor subunits gene expression, which are essential for learning and memory. These data demonstrate that riluzole exerts a disease modifying effect in an A\u03b2 mouse model of early-onset familial AD.<\/jats:p>","DOI":"10.1038\/s41398-018-0201-z","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T11:44:44Z","timestamp":1534247084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Masahiro","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe S.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Faraz","family":"Kazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Soya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"201_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"G McKhann","year":"2011","unstructured":"McKhann, G. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging- Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"201_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.1996.tb05866.x","volume":"94","author":"H Braak","year":"1996","unstructured":"Braak, H. & Braak, E. Evolution of the neuropathology of Alzheimer\u2019s disease. Acta Neurol. Scand. 94, 3\u201312 (1996).","journal-title":"Acta Neurol. Scand."},{"key":"201_CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","volume":"13","author":"Alzheimer\u2019s Association.","year":"2017","unstructured":"Alzheimer\u2019s Association. 2017 Alzheimer\u2019s Disease Facts and Figures. Alzheimers Dement. 13, 325\u2013373 (2017).","journal-title":"Alzheimers Dement."},{"key":"201_CR4","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.1421285111","volume":"111","author":"AC Pereira","year":"2014","unstructured":"Pereira, A. C. et al. Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering. Proc. Natl Acad. Sci. USA 111, 18733\u201318738 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"201_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jnc.13230","volume":"135","author":"HC Hunsberger","year":"2015","unstructured":"Hunsberger, H. C. et al. Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression. J. Neurochem. 135, 381\u2013394 (2015).","journal-title":"J. Neurochem."},{"key":"201_CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon, G., Lacomblez, L. & Meininger, V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group. N. Engl. J. Med. 330, 585\u2013591 (1994).","journal-title":"N. Engl. J. Med."},{"key":"201_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/mp.2016.33","volume":"22","author":"AC Pereira","year":"2017","unstructured":"Pereira, A. C. et al. Age and Alzheimer\u2019s disease gene expression profiles reversed by the glutamate modulator riluzole. Mol. Psychiatry 22, 296\u2013305 (2017).","journal-title":"Mol. Psychiatry"},{"key":"201_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/mp.2008.106","volume":"15","author":"M Banasr","year":"2010","unstructured":"Banasr, M. et al. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol. Psychiatry 15, 501\u2013511 (2010).","journal-title":"Mol. Psychiatry"},{"key":"201_CR9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature01273","volume":"420","author":"JT Trachtenberg","year":"2002","unstructured":"Trachtenberg, J. T. et al. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 420, 788\u2013794 (2002).","journal-title":"Nature"},{"key":"201_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.conb.2008.08.013","volume":"18","author":"ME Larkum","year":"2008","unstructured":"Larkum, M. E. & Nevian, T. Synaptic clustering by dendritic signalling mechanisms. Curr. Opin. Neurobiol. 18, 321\u2013331 (2008).","journal-title":"Curr. Opin. Neurobiol."},{"key":"201_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nn1253","volume":"7","author":"A Polsky","year":"2004","unstructured":"Polsky, A., Mel, B. W. & Schiller, J. Computational subunits in thin dendrites of pyramidal cells. Nat. Neurosci. 7, 621\u2013627 (2004).","journal-title":"Nat. Neurosci."},{"key":"201_CR12","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/brain\/119.6.2001","volume":"119","author":"NC Fox","year":"1996","unstructured":"Fox, N. C. et al. Presymptomatic hippocampal atrophy in Alzheimer\u2019s disease. A longitudinal MRI study. Brain 119, 2001\u20132007 (1996).","journal-title":"Brain"},{"key":"201_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","volume":"344","author":"MJ West","year":"1994","unstructured":"West, M. J., Coleman, P. D., Flood, D. G. & Troncoso, J. C. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimers-disease. Lancet 344, 769\u2013772 (1994).","journal-title":"Lancet"},{"key":"201_CR14","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal \u03b2-Amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"201_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","volume":"33","author":"R Kimura","year":"2009","unstructured":"Kimura, R. & Ohno, M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol. Dis. 33, 229\u2013235 (2009).","journal-title":"Neurobiol. Dis."},{"key":"201_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-2","volume":"8","author":"WA Eimer","year":"2013","unstructured":"Eimer, W. A. & Vassar, R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal A\u03b242 accumulation and Caspase-3 activation. Mol. Neurodegener. 8, 1\u201312 (2013).","journal-title":"Mol. Neurodegener."},{"key":"201_CR17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00213-011-2403-4","volume":"219","author":"SL Gourley","year":"2012","unstructured":"Gourley, S. L., Espitia, J. W., Sanacora, G. & Taylor, J. R. Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice. Psychopharmacol. (Berl.) 219, 805\u2013814 (2012).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"201_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/srep45306","volume":"7","author":"S Coli\u00e9","year":"2017","unstructured":"Coli\u00e9, S. et al. Neuronal p38\u03b1 mediates synaptic and cognitive dysfunction in an Alzheimer\u2019s mouse model by controlling \u03b2-amyloid production. Sci. Rep. 7, 45306 (2017).","journal-title":"Sci. Rep."},{"key":"201_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19699-y","volume":"8","author":"A Boza-Serrano","year":"2018","unstructured":"Boza-Serrano, A., Yang, Y., Paulus, A. & Deierborg, T. Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer\u2019s disease mouse model 5xFAD. Sci. Rep. 8, 1550 (2018).","journal-title":"Sci. Rep."},{"key":"201_CR20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2014.07.001","volume":"71","author":"SF Kazim","year":"2014","unstructured":"Kazim, S. F. et al. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 71, 110\u2013130 (2014).","journal-title":"Neurobiol. Dis."},{"key":"201_CR21","first-page":"973","volume":"3","author":"B Gelaye","year":"2016","unstructured":"Gelaye, B., Rondon, M. & Araya, P. R. A PM. A\u03b2 extraction from murine brain homogenates. Bio Protoc. 3, 973\u2013982 (2016).","journal-title":"Bio Protoc."},{"key":"201_CR22","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1523\/JNEUROSCI.1000-15.2015","volume":"35","author":"BT Casali","year":"2015","unstructured":"Casali, B. T. et al. Omega-3 fatty acids augment the actions of nuclear receptor agonists in a mouse model of Alzheimer\u2019s disease. J. Neurosci. 35, 9173\u20139181 (2015).","journal-title":"J. Neurosci."},{"key":"201_CR23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00308476","volume":"83","author":"PG Vallet","year":"1992","unstructured":"Vallet, P. G. et al. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease. Acta Neuropathol. 83, 170\u2013178 (1992).","journal-title":"Acta Neuropathol."},{"key":"201_CR24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","volume":"122","author":"C Dai","year":"2015","unstructured":"Dai, C. et al. Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies. J. Neural Transm. 122, 607\u2013617 (2015).","journal-title":"J. Neural Transm."},{"key":"201_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2010-11-8-r86","volume":"11","author":"J Goecks","year":"2010","unstructured":"Goecks, J., Nekrutenko, A. & Taylor, J., Galaxy Team T. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 11, R86 (2010).","journal-title":"Genome Biol."},{"key":"201_CR26","first-page":"1","volume-title":"Current Protocols in Molecular Biology.","author":"D Blankenberg","year":"2010","unstructured":"Blankenberg, D. et al. Galaxy: A Web-Based Genome Analysis Tool for Experimentalists. Current Protocols in Molecular Biology. (pp. 1\u201321. John Wiley & Sons, Inc, Hoboken, NJ, USA, 2010)."},{"key":"201_CR27","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"201_CR28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"201_CR29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"201_CR30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1037\/0735-7044.110.6.1321","volume":"110","author":"CD Conrad","year":"1996","unstructured":"Conrad, C. D., Galea, L. A., Kuroda, Y. & McEwen, B. S. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav. Neurosci. 110, 1321\u20131334 (1996).","journal-title":"Behav. Neurosci."},{"key":"201_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0006-8993(92)91352-F","volume":"588","author":"F Dellu","year":"1992","unstructured":"Dellu, F., Mayo, W., Cherkaoui, J., Le Moal, M. & Simon, H. A two-trial memory task with automated recording: study in young and aged rats. Brain Res. 588, 132\u2013139 (1992).","journal-title":"Brain Res."},{"key":"201_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E. & De Strooper, B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"201_CR33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat. Rev. Mol. Cell Biol. 8, 101\u2013112 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"201_CR34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0197-4580(00)00249-9","volume":"22","author":"MN Gordon","year":"2001","unstructured":"Gordon, M. N. et al. Correlation between cognitive deficits and Abeta deposits in transgenic APP\u2009+\u2009PS1 mice. Neurobiol. Aging 22, 377\u2013385 (2001).","journal-title":"Neurobiol. Aging"},{"key":"201_CR35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hipo.22267","volume":"24","author":"SD Girard","year":"2014","unstructured":"Girard, S. D. et al. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer\u2019s disease. Hippocampus 24, 762\u2013772 (2014).","journal-title":"Hippocampus"},{"key":"201_CR36","doi-asserted-by":"crossref","first-page":"12252","DOI":"10.1523\/JNEUROSCI.1305-10.2010","volume":"30","author":"L Crews","year":"2010","unstructured":"Crews, L. et al. Increased BMP6 levels in the brains of Alzheimer\u2019s disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J. Neurosci. 30, 12252\u201312262 (2010).","journal-title":"J. Neurosci."},{"key":"201_CR37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hipo.20428","volume":"18","author":"D Li","year":"2008","unstructured":"Li, D. et al. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe\/PS1??E9 mouse model of Alzheimer\u2019s disease. Hippocampus 18, 692\u2013698 (2008).","journal-title":"Hippocampus"},{"key":"201_CR38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T., Golenbock, D. T. & Latz, E. Innate immunity in Alzheimer\u2019s disease. Nat. Immunol. 16, 229\u2013236 (2015).","journal-title":"Nat. Immunol."},{"key":"201_CR39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky, O. et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131\u2013143 (2014).","journal-title":"Nat. Neurosci."},{"key":"201_CR40","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"201_CR41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-1326-9-33","volume":"9","author":"V Landel","year":"2014","unstructured":"Landel, V. et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer\u2019s disease. Mol. Neurodegener. 9, 33 (2014).","journal-title":"Mol. Neurodegener."},{"key":"201_CR42","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1523\/JNEUROSCI.0410-14.2014","volume":"34","author":"NS Woodling","year":"2014","unstructured":"Woodling, N. S. et al. Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling. J. Neurosci. 34, 5882\u20135894 (2014).","journal-title":"J. Neurosci."},{"key":"201_CR43","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J.-C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"201_CR44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1088\u20131093 (2009).","journal-title":"Nat. Genet."},{"key":"201_CR45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/dneu.20892","volume":"72","author":"B Goellner","year":"2012","unstructured":"Goellner, B. & Aberle, H. The synaptic cytoskeleton in development and disease. Dev. Neurobiol. 72, 111\u2013125 (2012).","journal-title":"Dev. Neurobiol."},{"key":"201_CR46","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.neurobiolaging.2015.07.003","volume":"36","author":"CM Fernandez-Martos","year":"2015","unstructured":"Fernandez-Martos, C. M., King, A. E., Atkinson, R. A. K., Woodhouse, A. & Vickers, J. C. Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP\/PS1 transgenic model of Alzheimer\u2019s disease. Neurobiol. Aging 36, 2757\u20132767 (2015).","journal-title":"Neurobiol. Aging"},{"key":"201_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001670","volume":"11","author":"B Ritter","year":"2013","unstructured":"Ritter, B. et al. NECAP 1 regulates AP-2 interactions to control vesicle size, number, and cargo during clathrin-mediated endocytosis. PLoS Biol. 11, e1001670 (2013).","journal-title":"PLoS Biol."},{"key":"201_CR48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1034\/j.1600-0854.2002.030406.x","volume":"3","author":"S Monier","year":"2002","unstructured":"Monier, S., Jollivet, F., Janoueix-Lerosey, I., Johannes, L. & Goud, B. Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport. Traffic 3, 289\u2013297 (2002).","journal-title":"Traffic"},{"key":"201_CR49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrn3896","volume":"16","author":"SA Small","year":"2015","unstructured":"Small, S. A. & Petsko, G. A. Retromer in Alzheimer disease, Parkinson disease and other neurological disorders. Nat. Rev. Neurosci. 16, 126\u2013132 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"201_CR50","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1023\/A:1007675508413","volume":"25","author":"Ra Nixon","year":"2000","unstructured":"Nixon, Ra, Cataldo, A. M. & Mathews, P. M. The endosomal-lysosomal system of neurons in Alzheimer\u2019s disease pathogenesis: a review. Neurochem. Res. 25, 1161\u20131172 (2000).","journal-title":"Neurochem. Res."},{"key":"201_CR51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJMcibr0902052","volume":"361","author":"F Li","year":"2009","unstructured":"Li, F. & Tsien, J. Z. Memory and the NMDA receptors. N. Engl. J. Med. 361, 302\u2013303 (2009).","journal-title":"N. Engl. J. Med."},{"key":"201_CR52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0166-2236(87)90175-5","volume":"10","author":"GL Collingridge","year":"1987","unstructured":"Collingridge, G. L. & Bliss, T. V. P. NMDA receptors\u2014their role in long-term potentiation. Trends Neurosci. 10, 288\u2013293 (1987).","journal-title":"Trends Neurosci."},{"key":"201_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jnr.20093","volume":"77","author":"WJ Streit","year":"2004","unstructured":"Streit, W. J. Microglia and Alzheimer\u2019s disease pathogenesis. J. Neurosci. Res. 77, 1\u20138 (2004).","journal-title":"J. Neurosci. Res."},{"key":"201_CR54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna, M. & Wang, Y. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat. Rev. Neurosci. 17, 201\u2013207 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"201_CR55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"201_CR56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","volume":"43","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe, D. J. & Schenk, D. Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545\u2013584 (2003).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"201_CR57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla, F. M. & Oddo, S. Alzheimer\u2019s disease: Abeta, tau and synaptic dysfunction. Trends Mol. Med. 11, 170\u2013176 (2005).","journal-title":"Trends Mol. Med."},{"key":"201_CR58","doi-asserted-by":"crossref","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke, L. & Selkoe, D. J. Neurotoxicity of amyloid \u03b2-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2, a006338 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"201_CR59","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop, J. J. & Mucke, L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 17, 777\u2013792 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"201_CR60","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop, J. J. & Mucke, L. Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat. Neurosci. 13, 812\u2013818 (2010).","journal-title":"Nat. Neurosci."},{"key":"201_CR61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.12.008","volume":"26","author":"M Ohno","year":"2007","unstructured":"Ohno, M. et al. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice. Neurobiol. Dis. 26, 134\u2013145 (2007).","journal-title":"Neurobiol. Dis."},{"key":"201_CR62","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1523\/JNEUROSCI.4654-15.2016","volume":"36","author":"GD Manocha","year":"2016","unstructured":"Manocha, G. D. et al. APP regulates microglial phenotype in a mouse model of Alzheimer\u2019s disease. J. Neurosci. 36, 8471\u20138486 (2016).","journal-title":"J. Neurosci."},{"key":"201_CR63","doi-asserted-by":"crossref","first-page":"14456","DOI":"10.1074\/jbc.M313747200","volume":"279","author":"CM Sondag","year":"2004","unstructured":"Sondag, C. M. & Combs, C. K. Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells. J. Biol. Chem. 279, 14456\u201314463 (2004).","journal-title":"J. Biol. Chem."},{"key":"201_CR64","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1523\/JNEUROSCI.5171-13.2014","volume":"34","author":"HA Born","year":"2014","unstructured":"Born, H. A. et al. Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer\u2019s disease. J. Neurosci. 34, 3826\u20133840 (2014).","journal-title":"J. Neurosci."},{"key":"201_CR65","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.278.5337.412","volume":"278","author":"JH Morrison","year":"1997","unstructured":"Morrison, J. H. & Hof, P. R. Life and death of neurons in the aging brain. Science 278, 412\u2013419 (1997).","journal-title":"Science"},{"key":"201_CR66","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0079-6123(02)36039-4","volume":"136","author":"JH Morrison","year":"2002","unstructured":"Morrison, J. H. & Hof, P. R. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer\u2019s disease. Prog. Brain. Res. 136, 467\u2013486 (2002).","journal-title":"Prog. Brain. Res."},{"key":"201_CR67","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","volume":"37","author":"F Kamenetz","year":"2003","unstructured":"Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925\u2013937 (2003).","journal-title":"Neuron"},{"key":"201_CR68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada, K. et al. Neuronal activity regulates extracellular tau in vivo. J. Exp. Med. 211, 387\u2013393 (2014).","journal-title":"J. Exp. Med."},{"key":"201_CR69","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler, A. M., Phillips, E. C., Lau, D. H. W., Noble, W. & Hanger, D. P. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 14, 389\u2013394 (2013).","journal-title":"EMBO Rep."},{"key":"201_CR70","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu, J. W. et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. 19, 1085\u20131092 (2016).","journal-title":"Nat. Neurosci."},{"key":"201_CR71","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li, S. et al. Soluble oligomers of amyloid \u03b2 protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788\u2013801 (2009).","journal-title":"Neuron"},{"key":"201_CR72","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","volume":"31","author":"S Li","year":"2011","unstructured":"Li, S. et al. Soluble A oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J. Neurosci. 31, 6627\u20136638 (2011).","journal-title":"J. Neurosci."},{"key":"201_CR73","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham, G. E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682\u2013696 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"201_CR74","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0306-4522(03)00028-9","volume":"118","author":"JM Williams","year":"2003","unstructured":"Williams, J. M. et al. Long-term regulation of N-methyl-D-aspartate receptor subunits and associated synaptic proteins following hippocampal synaptic plasticity. Neuroscience 118, 1003\u20131013 (2003).","journal-title":"Neuroscience"},{"key":"201_CR75","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0092-8674(00)81827-9","volume":"87","author":"JZ Tsien","year":"1996","unstructured":"Tsien, J. Z., Huerta, P. T. & Tonegawa, S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87, 1327\u20131338 (1996).","journal-title":"Cell"},{"key":"201_CR76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroscience.2008.01.080","volume":"158","author":"MA Martel","year":"2009","unstructured":"Martel, M. A., Wyllie, D. J. A. & Hardingham, G. E. In developing hippocampal neurons, NR2B-containing N-methyl-d-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158, 334\u2013343 (2009).","journal-title":"Neuroscience"},{"key":"201_CR77","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.0605238103","volume":"103","author":"L Groc","year":"2006","unstructured":"Groc, L. et al. NMDA receptor surface mobility depends on NR2A-2B subunits. Proc. Natl Acad. Sci. USA 103, 18769\u201318774 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"201_CR78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jnr.20865","volume":"84","author":"RN Christensen","year":"2006","unstructured":"Christensen, R. N., Ha, B. K., Sun, F., Bresnahan, J. C. & Beattie, M. S. Kainate induces rapid redistribution of the actin cytoskeleton in ameboid microglia. J. Neurosci. Res. 84, 170\u2013181 (2006).","journal-title":"J. Neurosci. Res."},{"key":"201_CR79","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1460-9568.2009.06659.x","volume":"29","author":"GJ Liu","year":"2009","unstructured":"Liu, G. J., Nagarajah, R., Banati, R. B. & Bennett, M. R. Glutamate induces directed chemotaxis of microglia. Eur. J. Neurosci. 29, 1108\u20131118 (2009).","journal-title":"Eur. J. Neurosci."},{"key":"201_CR80","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1523\/JNEUROSCI.18-06-02161.1998","volume":"18","author":"DT Weldon","year":"1998","unstructured":"Weldon, D. T. et al. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18, 2161\u20132173 (1998).","journal-title":"J. Neurosci."},{"key":"201_CR81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jemt.1121","volume":"54","author":"ME Bamberger","year":"2001","unstructured":"Bamberger, M. E. & Landreth, G. E. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer\u2019s disease. Microsc. Res. Tech. 54, 59\u201370 (2001).","journal-title":"Microsc. Res. Tech."},{"key":"201_CR82","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1471-4159.2010.06783.x","volume":"114","author":"T Heurtaux","year":"2010","unstructured":"Heurtaux, T. et al. Microglial activation depends on beta-amyloid conformation: role of the formylpeptide receptor 2. J. Neurochem. 114, 576\u2013586 (2010).","journal-title":"J. Neurochem."},{"key":"201_CR83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky, S. T. & Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann. Neurol. 27, 457\u2013464 (1990).","journal-title":"Ann. Neurol."},{"key":"201_CR84","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease is a synaptic failure. Science 298, 789\u2013791 (2002).","journal-title":"Science"},{"key":"201_CR85","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."}],"updated-by":[{"DOI":"10.1038\/s41398-019-0408-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000}}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0201-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:26:07Z","timestamp":1671517567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0201-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1038\/s41398-018-0201-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"9 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author\u2019s name was spelled incorrectly as \u201cMasahir Okamoto\u201d. This has been updated to \u201cMasahiro Okamoto\u201d in the HTML and PDF of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"153"}}